An interventional study of Surgical Treatment for Impacted Femoral Neck Fracture in Femoral Neck Fractures, sponsored by Nanjing First Hospital, Nanjing Medical University. Completed. Open to participants aged 75 Years to 97 Years. Per ClinicalTrials.gov, last updated 2020-01-07.
Sponsored by Nanjing First Hospital, Nanjing Medical University · Not applicable, Interventional, and Treatment
The purpose of the study is to evaluate the safety and effectiveness of conservative treatment in treatment of patients over 75 years with impacted femoral neck fracture.
The study is to compare clinical outcomes between conservative treatment, internal fixation, and hemiarthroplasty in patients over 75 years with impacted femoral neck fracture. All the 3 groups were evaluated by hip pain(visual analogue scale,VAS), hip function(Harris hip score,HHS), health related quality of life(European Quality of Life-5 Dimensions index scores, Eq-5d). All thses parameters were assessed at admission and 1-, 3-, 6- 12-, 24- and 36 months after intervention. Operation duration and blood loss were recorded. Mortality, union rate, complications and re-operation were also monitored throughout the study.
210 studies on the registry are indexed under Femoral Neck Fractures; 42 are open to participants now.
This study's enrollment of 154 is above the median of 100 across 146 interventional studies indexed under Femoral Neck Fractures.
Browse Femoral Neck Fractures studies →Nanjing First Hospital, Nanjing Medical University is the lead sponsor of 220 studies on the registry; 107 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients >75 years old who were diagnosed with impacted femoral neck fracture with confirmation of mutual embedding and close combination of the fracture ends by CT or MRI scanning(including Garden 1 and 2 and varus impacted FNF) were eligible for the inclusion.
Exclusion Criteria:
Patients \<75 years old, pathological fracture, nonimpacted or displaced fracture, unable to walk previously, avascular necrosis of femoral head, previous symptomatic hip pathology (such as arthritis), infection, a history of fracture in the studied hip, deformity of lower limb.
Conservative Treatment for Impacted Femoral Neck Fracture
Procedure: Surgical Treatment for Impacted Femoral Neck Fracture
Surgical Treatment for Impacted Femoral Neck Fracture
visual analog scale
visual analog scale(0-10 scores) is for pain, 0 represent no pain, 10 score represent
Time frame: 36 months
Harris hip score
The score has a maximum of 100 points (no disability), covering pain (0-44 points), function (0-47 points), and range of motion and absence of deformity (0-9 points).
Time frame: 36 months
Eq-5d index scores
To rate current state of health on five dimensions (mobility, personal hygiene, usual activities, pain/discomfort, and anxiety/depression) with three possible responses for each item (no problem, some problem, unable/large problem). Integral formula: V=1-Constant-Mobility-Self-care-Usual activity-Pain/discomfort-Anxiety/depression-N3.
Time frame: 36 months
No study locations are listed for this record.
Ran from Jan 2010 to primary completion in Oct 2016, 81 months.
Of 68 non-industry interventional studies with no phase under Femoral Neck Fractures, half reached primary completion within 46 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 62. This study's 81 months is above that.
Counting every sponsor, half of 74 studies reached it within 47 months; a quarter within 25 and three quarters within 63.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nanjing First Hospital, Nanjing Medical University →